Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.

Biotechnology

Tvardi Therapeutics

Tvardi Therapeutics' headquarters in Houston, TX, United States

Imran Alibhai

Jeffrey Larson, PhD, DABT

Dan Conn

John Kauh

Jeff Larson

Wallace Hall

Michael Wyzga

Sujal Shah

David Tweardy

Ravi I. Thadhani

Michael T. Lewis

Ron DePinho

Keith T. Flaherty

James P. Allison

Jamie McNab

The Scientific Advisory Board at Tvardi Therapeutics provides strategic guidance and expert insights to advance the company's clinical and preclinical programs. Comprised of distinguished scientists and industry leaders, the board collaborates closely with the R&D team to ensure scientific rigor and innovation in developing breakthrough medicines for cancer, chronic inflammatory diseases, and fibrotic diseases.

Scientific Advisory Board

The Leadership Team at Tvardi Therapeutics is responsible for setting the strategic vision and direction of the company, ensuring alignment between research, clinical development, and operational initiatives. Comprised of experienced executives and scientists, the team drives innovation, oversees the advancement of therapeutic candidates, and fosters collaboration across departments to achieve the company’s mission of developing breakthrough medicines for various diseases.

Leadership Team

Tvardi Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Board

Leadership Team

Offices

Tvardi Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Board

Leadership Team

Offices

Related companies